HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 16748343, compound → N-{4-[(6-{4-[(1R)-1-(4-fluorophenyl)ethyl]piperazin-1-yl}pyrimidin-4-yl)oxy]-1,3-benzothiazol-2-yl}acetamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 16748343 | HCID 16748343 | — |
| Reactant | 1,1-Dimethylethyl 4-[(1R)-1-(4-fluorophenyl)ethyl]-1-piperazinecarboxylate | HCID 16748799 | — |
| Product | N-{4-[(6-{4-[(1R)-1-(4-fluorophenyl)ethyl]piperazin-1-yl}pyrimidin-4-yl)oxy]-1,3-benzothiazol-2-yl}acetamide | HCID 11352366 | — |
Reaction Steps
According to the procedures described in Example 21(b), 4-[(1R)-1-(4-fluoro-phenyl)-ethyl]-piperazine-1-carboxylic acid tert-butyl ester, Example 21(a), (0.48 g, 1.6 mmol) and N-[4-(6-chloro-pyrimidin-4-yloxy)-benzothiazol-2-yl]-acetamide, Example 1(b), (0.512 g, 1.6 mmol) provided the title compound as a white solid. M.p.: 243.8-245.9° C. MS (ESI, pos. ion.) m/z: 493 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07511044B2 |
| Source dataset | uspto-grants-2009_03 |
| ORD ID | ord-9cecf2ea9b4d4387b2f625c003d5cae9 |
| Source note | uspto-grants-2009_03 |